Search Go
Follow Us:  linkedin twitter slideshare youtube google + pinterest
 


Medical Affairs Consortium
Our research & advisory services members:

  • Amgen
  • astellas
  • Actavis
  • BoehringerIngelheim
  • Biogen
  • Baxter
  • Celgene
  • Eisai
  • Lilly
  • Genentech
  • Incyte
  • Lundbeck
  • Merck
  • Mylan
  • Pfizer
  • Prostrakan
  • Sanofi
  • Shionogi
  • Sunovion
  • Teva
  • Upsher-Smith

What is the Medical Affairs Consortium?

The Medical Affairs Consortium service is a unique opportunity for the industry leaders to discuss key challenges, develop action-oriented solutions and uncover recent and future trends in regards to the function and its interactions with other critical functions.

Service Model:

Our seasoned research team establishes Medical Affairs research information from around the healthcare sector. Armed with these critical insights, our client members then embark on a networking and performance improvement conversation utterly unique to the industry.

Medical Affairs Consortium members have the following benefits:

  • Receive three customized research deliverables that help them compare their organization to the benchmark class
  • Get the chance to participate in three roundtable session to discuss their issues, solutions and best practices with the leaders from peer companies
  • Receive three roundtable discussion summaries that combine the lessons learned from these roundtable sessions

Formed in 2012, the Medical Affairs Consortium:

  • Has engaged nearly one hundred leading biopharma and medical device executives in benchmarking research to accelerated knowledge exchange
  • Has hosted six roundtable meetings and research deliverables composed of action-oriented insights from industry leaders
  • Has developed thirteen members from top biopharmaceutical companies


2015 - 2016 key events
August
  • Launch - Medical Affairs Consortium Survey
  • Medical Affairs Executives Participate in the Survey
  • November
  • Delivery of First Wave of Research Insights & Customized Analysis
  • First Roundtable Peer Panel & Knowledge Exchange
  • Delivery of First Roundtable Key Insights
  • February
  • Delivery of Second Wave of Research Insights & Customized Analysis
  • Second Roundtable Peer Panel & Knowledge Exchange
  • Delivery of Second Roundtable Key Insights
  • June
  • Delivery of Third Wave of Research Insights & Customized Analysis
  • Third Roundtable Peer Panel & Knowledge Exchange
  • Delivery of Third Roundtable Key Insights

  • Member-driven research:
    POP-259 Report Medical Affairs’ Role in Health Economics & Outcomes Research (ID POP-259)
    This study engaged 23 executives from 23 leading life sciences companies. Segmentation analysis was key to examining trends and effective practices.
    Read More Arrow Bullet
    POP-256 Report Medical Affairs’ Role in Ensuring Excellence in Product Launch (ID POP-256)
    Best Practices, LLC engaged 28 executives from 24 leading biopharmaceutical companies within mature markets. Segmentation analysis was key to examining trends and effective practices.
    Read More Arrow Bullet
    POP-255 Report Best Practices in Developing Top-Tier Medical Affairs Capabilities, Creating Impact Measures and Improving Globalization (ID POP-255)
    This study engaged 29 executives from 26 leading life sciences companies. Segmentation analysis was key to examining trends and effective practices.
    Read More Arrow Bullet
    POP-251 Report Best Practices In Aligning the Medical Affairs Function to Meet Its Role in a Changing Healthcare Environment (ID POP-251)
    This study engaged executives from 30 leading health care companies. Segmentation analysis was key to examining trends and effective practices.
    Read More Arrow Bullet
    Schedule a Meeting with Our Experts

    Weekly Research Release

    consortium infographic


    Medical Affairs Collateral 2015





     
    ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
    Quick Links  Product RSS Feed
    Payment gateway
    Secured by PayPal

    Follow Us: 

    linkedin twitter slideshare youtube google + pinterest

    All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
    Read our Terms and Conditions of Use, Privacy Policy and Copyright Information